RESUMEN
There is little information on patients 50 years or older with HIV infection since the start of the HAART era. We performed a descriptive cross-sectional study during 2004 including 28 patients aged 52 to 87 years. Eighteen patients were men (64%) and sexual transmission was the risk factor in 23 (81%). Four patients (14%) fulfilled slow progression criteria and 13 (46%) belonged to the C3 category. Twenty-four patients were on HAART, with optimal adherence. All the patients were receiving HIV-unrelated medications to treat comorbid conditions. Hence, the profile of these patients is as follows: mainly male with sexually transmitted infection, severe immunodeficiency at the diagnosis, and frequent comorbid processes.
Asunto(s)
Terapia Antirretroviral Altamente Activa , Infecciones por VIH/epidemiología , Anciano , Anciano de 80 o más Años , Recuento de Linfocito CD4 , Comorbilidad , Estudios Transversales , Progresión de la Enfermedad , Utilización de Medicamentos/estadística & datos numéricos , Femenino , Infecciones por VIH/tratamiento farmacológico , Infecciones por VIH/inmunología , Infecciones por VIH/transmisión , Humanos , Masculino , Persona de Mediana Edad , Cooperación del Paciente , España/epidemiología , Carga ViralRESUMEN
Existe poca información de los pacientes mayores de 50 años con infección por virus de la inmunodeficiencia humana (VIH) desde el inicio de la terapia antirretroviral de gran actividad (TARGA). Presentamos el estudio transversal descriptivo en 2004 de 28 pacientes (edades entre 52 y 87 años), 18 varones (64%). Contagio por vía sexual, 23 pacientes (81%). Cuatro (14%) son progresadores lentos, 13 (46%) categoría C3. Veinticuatro están con TARGA con alta adherencia al tratamiento. Todos realizan tratamiento con otras medicaciones por comorbilidades asociadas. El paciente tipo es un varón, heterosexual, grave inmunodeficiencia al diagnóstico y frecuente comorbilidad asociada (AU)
There is little information on patients 50 years or older with HIV infection since the start of the HAART era. We performed a descriptive cross-sectional study during 2004 including 28 patients aged 52 to 87 years. Eighteen patients were men (64%) and sexual transmission was the risk factor in 23 (81%). Four patients (14%) fulfilled slow progression criteria and 13 (46%) belonged to the C3 category. Twenty-four patients were on HAART, with optimal adherence. All the patients were receiving HIV-unrelated medications to treat comorbid conditions. Hence, the profile of these patients is as follows: mainly male with sexually transmitted infection, severe immunodeficiency at the diagnosis, and frequent comorbid processes (AU)